"We have received requests from a number of Governments and the EU to take further steps in relation to Russian state-controlled media," Nick Clegg, President of Global Affairs at Meta (Facebook) said through his Tweet on Twitter
Sputnik Light Covid vaccine is the 9th vaccine to be approved for emergency use in India.
The interim data of the efficacy trial from Russia has shown an efficacy of 65.4 per cent against COVID-19, 21 days after immunisation.
With Omicron raising concerns about Covid vaccines' efficacy, drugmakers are stress-testing existing jabs while also racing to prepare new formulas.
Russia's Health Ministry will register the Sputnik vaccine for children aged 12-17 on Wednesday, with shots expected to be available at the end of December.
CDSCO in July had refused to grant emergency-use authorisation to Sputnik-Light, ruling out the need for the conduct of the phase III trial of the Russian vaccine in the country.
The development came following the announcement that Panacea Biotec supplied the first shipment of the second component of the Russian Sputnik V vaccine manufactured by it for sale in India.
Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft-launched the vaccine in India in May 2021 after receiving Emergency Use Authorization (EUA) in April 2021.
"India's cumulative COVID vaccination coverage has surpassed 40 crore (40,44,67,526)," according to a provisional report compiled at 7 pm.
The new study examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly.
The Chief Medical Officer (CMO) of Gurugram, Virender Yadav, said that the vaccination drive will be stated at 12.00 at the government polyclinic sector-31 and 50 doses will be available on the first day.
Deputy Mayor Anastasia Rakova said 100 volunteers have been recruited who haven't been previously infected with the coronavirus and don't have health issues that would prevent them from getting the shots.
India's drug regulator has refused to grant emergency-use authorisation to single-dose COVID-19 vaccine Sputnik-Light, while ruling out the need for the conduct of the phase-3 trial of the Russian vaccine in the country.
A spokesperson of Apollo Hospitals said the facility in Delhi will tentatively start administering 2-dose vaccine by June 25.
The limited pilot soft launch of the Sputnik V vaccine in India has now been successfully scaled up to other cities including Delhi, Bengaluru, Mumbai, Chennai and Kolkata.
Apart from the Apollo hospital, another private hospital Madhukar Rainbow Children's Hospital will start administering the Sputnik V by the end of this week
The Central government on Tuesday also said that it has decided to increase the supply of two made-in-India vaccines - Covishield and Covaxin.
According to the data from over 186,000 people aged 60-79, more than 40,000 of whom received a shot of Sputnik Light (first dose of Sputnik V) as part of the mass-scale civil vaccination program, the infection rate between 21st and 40th day from the date of receiving the first dose was only 0.446 per cent.
More than 18 million doses of the Russian vaccine Sputnik-V will be available for Indians by August, while Indian partners are expected to produce about 850 million doses of the vaccine by March 2022
Top News
Latest News
